A comprehensive developer guide to implementing secure authentication in modern applications. Covers OAuth 2.0, OIDC, ...

Stock splits don’t boost intrinsic value, but they lead to higher trading volumes and more attention from investors. Identifying stocks before splits are announced can lead to higher returns, but it’s ...

Investors are watching Palantir for a potential stock split, but the more important point is what splits do (and don’t) change for shareholders. Split “rallies” often coincide with strong pre-existing ...

Tyler, the Creator has spent almost his entire life trying to be a star. From an early age he wanted to make music, and has been tunnel-visioned on that goal ever since. “I knew what I was going to do ...

Faith writes guides, how-tos, and roundups on the latest Android games and apps for Android Police. You'll find her writing about the newest free-to-play game to hit Android or discussing her paranoia ...

Remember earlier this year when a bunch of Disney characters and civil rights activists were being puppeteered on social media by generative AI prompts? Disney sent a cease-and-desist to Character.ai, ...

A rift is forming within the FBI on how hard to go after the six Democratic lawmakers President Trump accused of “seditious behavior” over a video imploring military service members to “refuse illegal ...

Lionsgate on Thursday, Nov. 20, released an official teaser trailer to the anticipated 2026 film, "The Hunger Games: Sunrise on the Reaping." The movie is based on the novel by author and Indiana ...

William Parks is a Game Rant editor from the USA. Upon graduating from the University of Southern California’s School of Cinematic Arts, William entered the realm of fine arts administration, ...

The proposal is a response to redrawn congressional district lines intended to favor Democrats. The plan faces significant hurdles as it requires approval from both the state legislature and U.S.

Johnson & Johnson said Tuesday it plans to separate its artificial hip and knee business into a stand-alone company to be called DePuy Synthes—the latest attempt to slim down by the healthcare giant.